YY1 Promotes Telomerase Activity and Laryngeal Squamous Cell Carcinoma Progression Through Impairment of GAS5-Mediated p53 Stability
Authors:
Open Access
- 23 August 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 11
Abstract
Yin Yang 1 (YY1) is a key transcription factor that exerts functional roles in the cell biological process of various cancers. The current study aimed to elucidate the role and mechanism of YY1 in laryngeal squamous cell carcinoma (LSCC). YY1 mRNA and protein expression in human LSCC cell lines was detected by RT-qPCR and Western blot analysis. An interaction of YY1, GAS5, and p53 protein stability was predicted and confirmed by bioinformatics, ChIP, Co-IP, RIP, and FISH assays. Following loss- and gain-function assays, LSCC cell proliferation, colony formation, cell cycle, telomere length and telomerase activity were evaluated by CCK-8 assay, colony formation assay, flow cytometry, and PCR-ELISA, respectively. Nude mice were xenografted with the tumor in vivo. LSCC cell lines presented with upregulated expression of YY1, downregulated GAS5 expression, and decreased p53 stability. YY1 inhibited the expression of GAS5, which in turn recruited p300 and bound to p53, thus stabilizing it. Moreover, YY1 could directly interact with p300 and suppressp53 stability, leading to enhancement of cell proliferation, telomere length and telomerase activity in vitro along with tumor growth in vivo. Collectively, YY1 can stimulate proliferation and telomerase activity of LSCC cells through suppression of GAS5-dependent p53 stabilization or by decreasing p53 stability via a direct interaction with p300, suggesting that YY1 presents a therapeutic target as a potential oncogene in LSCC development and progression.Keywords
This publication has 35 references indexed in Scilit:
- Role of lncRNAs in Cellular AgingFrontiers in Endocrinology, 2016
- An update on larynx cancerCA: A Cancer Journal for Clinicians, 2016
- Inflammatory potential of diet and risk of laryngeal cancer in a case–control study from ItalyCancer Causes & Control, 2016
- β-Elemene inhibits the proliferation of esophageal squamous cell carcinoma by regulating long noncoding RNA-mediated inhibition of hTERT expressionAnti-Cancer Drugs, 2015
- The Role of YY1 in Oncogenesis and Its Potential as a Drug Target in Cancer TherapiesCurrent Cancer Drug Targets, 2015
- Expression of YY1 in Differentiated Thyroid CancerEndocrine Pathology, 2015
- Targeting Tumor Suppressor p53 for Cancer Therapy: Strategies, Challenges and OpportunitiesCurrent Drug Targets, 2014
- Implications of galactocerebrosidase and galactosylcerebroside metabolism in cancer cellsInternational Journal of Cancer, 2005
- YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stressProceedings of the National Academy of Sciences, 2004
- Light-dependent activation of 7,12-dimethylbenz[a]anthracene to a potent genotoxicantCarcinogenesis, 1996